Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy
Junaid Alam, Lavita Kumari, Usman Shaikh, Kausar Jabeen & Muhammad Ali Akbar Khan · Asian Hematology Research Journal · 2024
Introduction: Acute myeloid leukemia (AML) is a hematologic malignancy with high mortality rates due to infections, treatment-related toxicity, and multidrug-resistant (MDR) organisms, especially in resource-limited settings. Standard induction therapy includes a cytarabine‒anthr...
Open access
Research Article
10.9734/ahrj/2024/v7i4186